Clinical Trials
5 trialsNCT00438880 2016-02-04
Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma
Mayo Clinic
Phase 1/2 Completed
NCT00185965 2014-08-01
CPG 7909 + Local Radiotherapy in Recurrent Low-Grade Lymphomas
Stanford University
Phase 1/2 Completed
NCT00031278 2011-05-30
Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer
Pfizer
Phase 1/2 Completed
NCT00043407 2009-02-12
CPG 7909 in Patients Wih Stage IV Renal Cell Cancer
Pfizer
Phase 1/2 Completed
NCT00043420 2009-02-12
CPG 7909 in Patients With Cutaneous T-Cell Lymphoma
Pfizer
Phase 1/2 Completed